| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/22/1999 | WO1999036069A1 Il-8 receptor antagonists |
| 07/22/1999 | WO1999036060A1 Oral liquid compositions |
| 07/22/1999 | WO1999036052A1 Mixture containing honey, at least one essential oil and/or at least one essential oil derivative |
| 07/22/1999 | WO1999035912A1 Tuberculocidal disinfectant |
| 07/22/1999 | WO1999027958A3 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 07/22/1999 | WO1999027793A3 An antimicrobial composition |
| 07/22/1999 | WO1999026632B1 Phospholipids having antimicrobial activity with or without the presence of antimicrobials |
| 07/22/1999 | WO1999024052A3 Use of protein h as cytostatic agent |
| 07/22/1999 | WO1999012971A3 Amino acid sequences for therapeutical and prophylactic applications to diseases due to clostridium difficile toxins |
| 07/22/1999 | DE19801821A1 Use of N-substituted glycine derivatives in tuberculocidal disinfectant |
| 07/22/1999 | CA2318439A1 Vaccine composition for herpes simplex virus and methods of using |
| 07/22/1999 | CA2318362A1 Triazine antiviral compounds |
| 07/22/1999 | CA2318357A1 Thioether furan nitrone compounds |
| 07/22/1999 | CA2318195A1 Il-8 receptor antagonists |
| 07/22/1999 | CA2317956A1 Mixture containing honey, at least one essential oil and/or at least one essential oil derivative |
| 07/22/1999 | CA2317942A1 Alkenyldiarylmethane non-nucleoside hiv-1 reverse transcriptase inhibitors |
| 07/22/1999 | CA2317895A1 Ribozymal nucleic acids cleaving ccr5 or cxcr4 |
| 07/22/1999 | CA2317815A1 Neisseria meningitidis antigens |
| 07/22/1999 | CA2317439A1 Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof, and methods of treating bacterial and microbial infections with inhibitors of bacterial nad synthetase enzyme |
| 07/22/1999 | CA2315760A1 Tuberculocidal disinfectant |
| 07/22/1999 | CA2315746A1 Lipooligosaccharide-based vaccine for prevention of moraxella (branhamella) catarrhalis infections in mammals |
| 07/22/1999 | CA2309546A1 N-[2-(5-benzyloxycarbonyl-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl)acetoxyl]-l-aspartic acid aldehyde as an in vivo inhibitor of interleukin-1.beta. converting enzyme (ice) |
| 07/21/1999 | EP0930297A1 A process for preparing naphthyridones and intermediates |
| 07/21/1999 | EP0929679A2 Histidine-tagged shiga toxins, toxoids, and protein fusions with such toxins and toxoids, methods for the purification and preparation thereof |
| 07/21/1999 | EP0929678A2 Protein and peptide vaccines for inducing mucosal immunity |
| 07/21/1999 | EP0929578A1 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 07/21/1999 | EP0929571A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 07/21/1999 | EP0929568A2 Pharmaceutical compositions for the treatment of immune disorders |
| 07/21/1999 | EP0929563A1 6-o-substituted ketolides having antibacterial activity |
| 07/21/1999 | EP0929533A1 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same |
| 07/21/1999 | EP0929517A1 Hydroxamic acid derivatives |
| 07/21/1999 | EP0929309A1 Pharmaceutical composition containing a mixed extract of phellodendron amurense ruprecht cortex and patrinia scabiosaefolia fisch. for treatment of hepatitis c |
| 07/21/1999 | EP0929300A2 Cyanidin compositions and therapeutic and diagnostic uses therefor |
| 07/21/1999 | EP0929217A1 Sordarin derivatives |
| 07/21/1999 | EP0765327B1 Pyrazolo and pyrrolopyridines |
| 07/21/1999 | CN1223655A 1-methylcarbapenem derivatives |
| 07/21/1999 | CN1223651A Substituted indazole derivatives and their use as phosphodiesterase (PDE) type IV and tumor necrosis factor (TNF) inhibitors |
| 07/21/1999 | CN1223586A Recombinant vaccine for diseases caused by encapsulated organisms |
| 07/21/1999 | CN1223581A Anti-vaginitis composition for topical use comprising one or more anti-vaginitis medicaments and one or more local anaesthetics |
| 07/21/1999 | CN1223576A Veterinary use of a pleuromutilin derivative |
| 07/21/1999 | CN1223546A Antimicrobial treatment for herpes simplex virus and other infectious diseases |
| 07/21/1999 | CN1223261A Novel 2-thiosubstituted carbapenems |
| 07/21/1999 | CN1044247C Penicillic olefin derivant and preparation process and use thereof |
| 07/21/1999 | CN1044236C Oxazolidinone antimicrobials containing substituted diazine moieties |
| 07/20/1999 | US5925789 Multistage process with amination, dehydration and stirring to give an intermediate in the synthesis of 6-chloro-4-cyclo propylethynyl-4-trifluoromethyl-1,4-2h-3,1-benzoxazine-2-one as an inhibitor of hiv reverse transcriptase |
| 07/20/1999 | US5925780 Viricides for retroviral species |
| 07/20/1999 | US5925772 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 07/20/1999 | US5925751 Human cytomegalovirus DNA sequences |
| 07/20/1999 | US5925733 DNA polymerase of gamma herpes viruses associated with Kaposi's sarcoma and retroperitoneal fibromatosis |
| 07/20/1999 | US5925667 Pyrrolidine derivative, anti-ulcer drug, and antibacterial drug |
| 07/20/1999 | US5925643 Treating human immunodeficiency virus infections |
| 07/20/1999 | US5925632 Derivatives of 3-pyrrolidylidene-2-one-cephalsporines |
| 07/20/1999 | US5925616 Synergistic mixtures |
| 07/20/1999 | US5925568 It is also useful to be able to harvest haematopoietic cells prior to chemotherapy or radiotherapy, thus protecting them from the effects of this therapy; after therapy, the cells can be returned to the patient. |
| 07/20/1999 | US5925550 Method for selectively increasing the ratio of single major components of antibiotic A/16686 complex |
| 07/20/1999 | US5925513 Diagnosis and treatment of AIDS onset |
| 07/20/1999 | US5925512 Monoclonal antibody which specifically binds to mutant hepatitis b virus surface antigen ?a? determinant |
| 07/20/1999 | US5925369 Bis alkanoyl esters of carnitine having bactericidal, fungicidal and antiprotozoal activity |
| 07/20/1999 | US5925361 Ornithobacterium rhinotracheale vaccines |
| 07/20/1999 | US5925360 Isolated dna sequence encoding protein of hog cholera virus or antigenic fragment comprising specified amino acid sequence |
| 07/20/1999 | US5925359 European vaccine strains of the porcine reproductive and respiratory syndrome virus |
| 07/20/1999 | US5925358 Insertion of dna into fowlpox virus genome |
| 07/20/1999 | US5925354 Riboflavin mutants as vaccines against Actinobacillus pleuropneumoniae |
| 07/20/1999 | CA1340672C Cephalosporin derivatives |
| 07/15/1999 | WO1999035271A2 Vibrio cholerae vaccine candidates and method of their constructing |
| 07/15/1999 | WO1999035270A1 Streptococcal heat shock proteins of the hsp60 family |
| 07/15/1999 | WO1999035247A1 Novel therapeutic uses of heterologous superoxide dismutase (hsd), and method for selecting said hsd |
| 07/15/1999 | WO1999035246A1 Novel steroid-activated nuclear receptors and uses therefor |
| 07/15/1999 | WO1999035164A1 Anti-cryptococcal peptides |
| 07/15/1999 | WO1999035158A1 36 human secreted proteins |
| 07/15/1999 | WO1999035157A1 Novel erythromycin derivatives |
| 07/15/1999 | WO1999035156A1 Novel macrolides |
| 07/15/1999 | WO1999035155A1 Novel aromatic amides, preparation method and application as medicines |
| 07/15/1999 | WO1999035153A1 Anthracycline glycosides |
| 07/15/1999 | WO1999034832A1 Crystallographically stable amorphous cephalosporin compositions and process for producing the same |
| 07/15/1999 | WO1999034826A1 Methods and compositions for desensitisation |
| 07/15/1999 | WO1999034805A1 Use of antimicrobial agent such as taurolidine or taurultam in the manufacture of a medicament to treat a nosocomial microbial infection |
| 07/15/1999 | WO1999034793A1 Pyronin antibacterials, process and novel intermediates thereto |
| 07/15/1999 | WO1999034777A1 Liposomes containing multiple branch peptide constructions for use against human immunodeficiency virus |
| 07/15/1999 | WO1999021582A3 Application of tnf antagonists as medicaments for treating septic diseases |
| 07/15/1999 | WO1999013095A9 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses |
| 07/15/1999 | DE19813759C1 Inducing a natural killer cell immune response ex vivo |
| 07/15/1999 | CA2317951A1 Novel aromatic amides, preparation method and application as medicines |
| 07/15/1999 | CA2317724A1 Methods and compositions for desensitisation |
| 07/15/1999 | CA2317702A1 36 human secreted proteins |
| 07/15/1999 | CA2315880A1 Streptococcal heat shock proteins of the hsp60 family |
| 07/15/1999 | CA2315156A1 Pyronin antibacterials, process and novel intermediates thereto |
| 07/14/1999 | EP0928787A1 Process for the preparation of 3-amino-pyrrolidine derivatives |
| 07/14/1999 | EP0928306A1 Antiviral linear polymers |
| 07/14/1999 | EP0928198A2 Vaccine composition comprising outer membrane protein fragments of bordetella pertussis |
| 07/14/1999 | EP0928192A1 Antimycotic gel with high active substance release |
| 07/14/1999 | EP0928136A2 Injectable compositions |
| 07/14/1999 | EP0759079B1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1-BETA CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICE rel-III) |
| 07/14/1999 | EP0754234B1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1 BETA CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE II (ICE rel-II) |
| 07/14/1999 | EP0730591B1 Esters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones |
| 07/14/1999 | EP0581856B1 Method of preventing nmda receptor complex-mediated neuronal damage |
| 07/14/1999 | CN1222912A Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| 07/14/1999 | CN1222905A New synthetic catechol derivatives, method for production and use thereof |
| 07/14/1999 | CN1222385A Reverse transcriptase inhibitor |
| 07/14/1999 | CN1044118C 7-Isoindolinyl-quinolone derivatives and its preparation |